Martin Edwards Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Martin Edwards.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Martin Edwards. Martin Edwards is a Director in KalVista Pharmaceuticals, Inc. ($KALV) and a Director in REATA PHARMACEUTICALS INC ($RETA) and a Director in Verona Pharma plc ($VRNA) and a Director in Inozyme Pharma, Inc. ($INZY).
Address: C/O COLUCID PHARMACEUTICALS, INC. 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON 01803 MA
Companies in which Martin Edwards is an Insider
Inozyme Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Edwards: Director
Holdings: 0 shares
Latest Transaction: Jul 24 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KalVista Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Edwards: Director
Holdings: 0 shares
Latest Transaction: Oct 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REATA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Edwards: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 04 2020
$RETA Market Capitalization: $515.29M
$RETA Previous Close: $23.03
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verona Pharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Edwards: Director
Holdings: 111,064 shares
Latest Transaction: May 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Martin Edwards
Sentiment: All, INZY, KALV, RETA, VRNA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | VRNA | Verona Pharma plc | Edwards Martin | Director | Sell | S | 0.84 | 12,024 | 10,097 | 111,064 | 123.1 K to 111.1 K (-9.77 %) |
| Feb 03 2021 | VRNA | Verona Pharma plc | Edwards Martin | Director | Sell | S | 0.99 | 13,688 | 13,603 | 123,088 | 136.8 K to 123.1 K (-10.01 %) |
| Oct 02 2020 | KALV | KalVista Pharmaceu ... | Edwards Martin | Director | Option Exercise | A | 12.88 | 7,000 | 90,160 | 7,000 | |
| Aug 04 2020 | RETA | REATA PHARMACEUTIC ... | Edwards Martin | Director | Option Exercise | A | 149.29 | 6,300 | 940,527 | 6,300 | |
| Aug 04 2020 | RETA | REATA PHARMACEUTIC ... | Edwards Martin | Director | Option Exercise | A | 149.29 | 10,000 | 1,492,900 | 10,000 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Edwards Martin | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Edwards Martin | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 |